MBRX
Moleculin Biotech, Inc.
stockNASDAQ
At CloseOct 27, 2026 3:59:49 PM EDT
9.20USD+29.852%(+2.12)183,669
After-hoursOct 27, 2026 4:54:30 PM EDT
9.75USD+5.978%(+0.55)
MBRX Financials
In Q2 FY 2026 (ended ), Moleculin Biotech, Inc. (MBRX) reported revenue of $0, net income of −$7.64M, operating cash flow of −$6.66M, and assets of $21.09M.
Loading financial statements…